Discovery of a potent and selective ATAD2 inhibitor with antiproliferative activity in breast cancer models

被引：0
|
作者：
Kulkarni, Meghana M. [1 ]
Winter, Jon [2 ]
Whalley, David [3 ]
Dale, Ian [2 ]
Denz, Christopher [1 ]
Guan, Nin [1 ]
Bhavsar, Deepa [1 ]
Zhang, Andrew [1 ]
Rasmusson, Timothy [1 ]
Fretland, Adrian [1 ]
Guichard, Sylvie M. [1 ]
机构：
[1] AstraZeneca, Waltham, MA USA
[2] AstraZeneca, Cambridge, England
[3] AstraZeneca, Waltham, England
来源：
MOLECULAR CANCER THERAPEUTICS | 2018年 / 17卷 / 01期
关键词：
D O I：
10.1158/1535-7163.TARG-17-A170
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A170
引用
收藏
页数：2
相关论文
共 50 条
  • [31] ATAD2 suppression enhances the combinatorial effect of gemcitabine and radiation in pancreatic cancer cells
    Dutta, Madhuri
    Mohapatra, Debasish
    Mohapatra, Amlan Priyadarshee
    Senapati, Shantibhusan
    Roychowdhury, Anasuya
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2022, 635 : 179 - 186
  • [32] Discovery of potent and selective spiroindolinone MDM2 inhibitor, RO8994, for cancer therapy
    Zhang, Zhuming
    Ding, Qingjie
    Liu, Jin-Jun
    Zhang, Jing
    Jiang, Nan
    Chu, Xin-Jie
    Bartkovitz, David
    Luk, Kin-Chun
    Janson, Cheryl
    Tovar, Christian
    Filipovic, Zoran M.
    Higgins, Brian
    Glenn, Kelli
    Packman, Kathryn
    Vassilev, Lyubomir T.
    Graves, Bradford
    BIOORGANIC & MEDICINAL CHEMISTRY, 2014, 22 (15) : 4001 - 4009
  • [33] MicroRNA-217 modulates pancreatic cancer progression via targeting ATAD2
    Dutta, Madhuri
    Das, Biswajit
    Mohapatra, Debasish
    Behera, Padmanava
    Senapati, Shantibhusan
    Roychowdhury, Anasuya
    LIFE SCIENCES, 2022, 301
  • [34] ATAD2 suppression enhances the combinatorial effect of gemcitabine and radiation in pancreatic cancer cells
    Dutta, Madhuri
    Mohapatra, Debasish
    Mohapatra, Amlan Priyadarshee
    Senapati, Shantibhusan
    Roychowdhury, Anasuya
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2022, 635 : 179 - 186
  • [35] Identification and characterization of a potent and selective HUNK inhibitor for treatment of HER2+breast cancer
    Dilday, Tinslee
    Abt, Melissa
    Ramos-Solis, Nicole
    Dayal, Neetu
    Larocque, Elizabeth
    Oblak, Adrian L.
    Sintim, Herman O.
    Yeh, Elizabeth S.
    CELL CHEMICAL BIOLOGY, 2024, 31 (05) : 989 - 999.e7
  • [36] Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity
    Tsai, James
    Lee, John T.
    Wang, Weiru
    Zhang, Jiazhong
    Cho, Hanna
    Mamo, Shumeye
    Bremer, Ryan
    Gillette, Sam
    Kong, Jun
    Haass, Nikolas K.
    Sproesser, Katrin
    Li, Ling
    Smalley, Keiran S. M.
    Fong, Daniel
    Zhu, Yong-Liang
    Marimuthu, Adhirai
    Nguyen, Hoa
    Lam, Billy
    Liu, Jennifer
    Cheung, Ivana
    Rice, Julie
    Suzuki, Yoshihisa
    Luu, Catherine
    Settachatgul, Calvin
    Shellooe, Rafe
    Cantwell, John
    Kim, Sung-Hou
    Schlessinger, Joseph
    Zhang, Kam Y. J.
    West, Brian L.
    Powell, Ben
    Habets, Gaston
    Zhang, Chao
    Ibrahim, Prabha N.
    Hirth, Peter
    Artis, Dean R.
    Herlyn, Meenhard
    Bollag, Gideon
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (08) : 3041 - 3046
  • [37] Discovery of Ecallantide: A potent and selective inhibitor of plasma kallikrein
    Ladner, R.
    Kent, R.
    Ley, A.
    Nixon, A.
    Sexton, D.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 119 (01) : S312 - S312
  • [38] Discovery of a potent and selective Axl inhibitor in preclinical model
    Inoue, Satoshi
    Yamane, Yoshinobu
    Tsukamoto, Shuntaro
    Azuma, Hiroshi
    Nagao, Satoshi
    Murai, Norio
    Nishibata, Kyoko
    Fukushima, Sayo
    Ichikawa, Kenji
    Nakagawa, Takayuki
    Sugi, Naoko Hata
    Ito, Daisuke
    Kato, Yu
    Goto, Aya
    Kakiuchi, Dai
    Ueno, Takashi
    Matsui, Junji
    Matsushima, Tomohiro
    BIOORGANIC & MEDICINAL CHEMISTRY, 2021, 39
  • [39] Isoform-Selective ATAD2 Chemical Probe with Novel Chemical Structure and Unusual Mode of Action
    Fernandez-Montalvan, Amaury E.
    Berger, Markus
    Kuropka, Benno
    Koo, Seong Joo
    Badock, Volker
    Weiske, Joerg
    Puetter, Vera
    Holton, Simon J.
    Stoekigt, Detlef
    ter Laak, Antonius
    Centrella, Paolo A.
    Clark, Matthew A.
    Dumelin, Christoph E.
    Sigel, Eric A.
    Soutter, Holly H.
    Troast, Dawn M.
    Zhang, Ying
    Cuozzo, John W.
    Keefe, Anthony D.
    Roche, Didier
    Rodeschini, Vincent
    Chaikuad, Apirat
    Diaz-Saez, Laura
    Bennett, James M.
    Fedorov, Oleg
    Huber, Kilian V. M.
    Huebner, Jan
    Weinmann, Hilmar
    Hartung, Ingo V.
    Gorjanacz, Matyas
    ACS CHEMICAL BIOLOGY, 2017, 12 (11) : 2730 - 2736
  • [40] ATAD2 Overexpression Identifies Colorectal Cancer Patients with Poor Prognosis and Drives Proliferation of Cancer Cells
    Luo, Yang
    Ye, Guang-Yao
    Qin, Shao-Lan
    Yu, Min-Hao
    Mu, Yi-Fei
    Zhong, Ming
    GASTROENTEROLOGY RESEARCH AND PRACTICE, 2015, 2015
12345